Platelet (PLT) support is critical to the care of patients with thrombocytopenia, but allogeneic transfusions carry risk. Pathogen reduction mitigates some transfusion risks, but effects on PLT function remain a concern. This clinical pilot study assessed the effect of pathogen reduction technology with riboflavin plus ultraviolet light using thrombelastography (TEG).
Transfusion, 2013, Vol 53, Issue 9, p. 2043-52
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't